Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Italian Real-life Multicenter Observational Study on Efficacy, Tolerability, and Safety of Innovative Drugs (Monoclonal Antibodies, Gepants, Ditans, Sumatriptan-naproxen) for Preventive or Acute Migraine Treatment.

NCT07103694 is registered in ClinicalTrials.gov with IRCCS San Raffaele Roma as lead sponsor.

NCT NCT07103694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07103694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Italian Real-life Multicenter Observational Study on Efficacy, Tolerability, and Safety of Innovative Drugs (Monoclonal Antibodies, Gepants, Ditans, Sumatriptan-naproxen) for Preventive or Acute Migraine Treatment.
Lead sponsor
IRCCS San Raffaele Roma
Phase
Observational
Overall status
Recruiting
Start date
March 24, 2022
Completion date
December 31, 2026
Enrollment
2,641 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic migraine, episodic migraine, medication overuse headache